FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2020709481> ?p ?o ?g. }

• W2020709481 endingPage "1114" @default.
• W2020709481 startingPage "1107" @default.
• W2020709481 abstract "Infusing natural killer (NK) cells following transplantation may allow less infections and relapse with little risk of acute graft-versus-host disease (aGVHD). We delivered 51 total NK cell-enriched donor lymphocyte infusions (DLIs) to 30 patients following a 3-6/6 HLA matched T cell-depleted nonmyeloablative allogeneic transplant. The primary endpoint of this study was feasibility and safety. Eight weeks following transplantation, donor NK cell-enriched DLIs were processed using a CD56(+) selecting column with up to 3 fresh infusions allowed. Toxicity, relapse, and survival were monitored. T cell phenotype, NK cell functional recovery, and KIR typing were assessed for association with outcomes. Fourteen matched and 16 mismatched transplanted patients received a total of 51 NK cell-enriched DLIs. Selection resulted in 96% (standard deviation [SD] 8%) purity and 83% (SD 21%) yield in the matched setting and 97% (SD 3%) purity and 77% (SD 24%) yield in the mismatched setting. The median number of CD3(-) CD56(+) NK cells infused was 10.6 (SD 7.91) x 10(6) cells/kg and 9.21 (SD 5.6) x 10(6) cells/kg, respectively. The median number of contaminating CD3(+)CD56(-) T cells infused was .53 (1.1) x 10(6) and .27 (.78) x 10(6) in the matched and mismatched setting, respectively. Only 1 patient each in the matched (n = 14) or mismatched (n = 16) setting experienced severe aGVHD with little other toxicity attributable to the infusions. Long-term responders with multiple NK cell-enriched infusions and improved T cell phenotypic recovery had improved duration of responses (p = .0045) and overall survival (OS) (P = .0058). A 1-step, high-yield process is feasible, and results in high doses of NK cells infused with little toxicity. NK cell-enriched DLIs result in improved immune recovery and outcomes for some. Future studies must assess whether the improved outcomes are the direct result of the high doses and improved NK cell function or other aspects of immune recovery." @default.
• W2020709481 created "2016-06-24" @default.
• W2020709481 creator A5013466160 @default.
• W2020709481 creator A5018522179 @default.
• W2020709481 creator A5018922885 @default.
• W2020709481 creator A5022333191 @default.
• W2020709481 creator A5027756167 @default.
• W2020709481 creator A5029909593 @default.
• W2020709481 creator A5033550793 @default.
• W2020709481 creator A5034651124 @default.
• W2020709481 creator A5037247107 @default.
• W2020709481 creator A5038246773 @default.
• W2020709481 creator A5043054254 @default.
• W2020709481 creator A5061865992 @default.
• W2020709481 creator A5071675435 @default.
• W2020709481 creator A5077339824 @default.
• W2020709481 creator A5081957836 @default.
• W2020709481 creator A5083678047 @default.
• W2020709481 creator A5090348866 @default.
• W2020709481 creator A5091207091 @default.
• W2020709481 date "2010-08-01" @default.
• W2020709481 modified "2023-10-16" @default.
• W2020709481 title "Natural Killer Cell-Enriched Donor Lymphocyte Infusions from A 3-6/6 HLA Matched Family Member following Nonmyeloablative Allogeneic Stem Cell Transplantation" @default.
• W2020709481 cites W1523122757 @default.
• W2020709481 cites W1600940429 @default.
• W2020709481 cites W1969814796 @default.
• W2020709481 cites W1971984984 @default.
• W2020709481 cites W1975040998 @default.
• W2020709481 cites W1979091618 @default.
• W2020709481 cites W1979849861 @default.
• W2020709481 cites W1983735618 @default.
• W2020709481 cites W1985331126 @default.
• W2020709481 cites W1997849135 @default.
• W2020709481 cites W2018922991 @default.
• W2020709481 cites W2042997234 @default.
• W2020709481 cites W2043969722 @default.
• W2020709481 cites W2046348840 @default.
• W2020709481 cites W2057781614 @default.
• W2020709481 cites W2059333195 @default.
• W2020709481 cites W2060136712 @default.
• W2020709481 cites W2073043652 @default.
• W2020709481 cites W2090735160 @default.
• W2020709481 cites W2097790514 @default.
• W2020709481 cites W2108395794 @default.
• W2020709481 cites W2111951140 @default.
• W2020709481 cites W2115721890 @default.
• W2020709481 cites W2147068163 @default.
• W2020709481 cites W2147548158 @default.
• W2020709481 cites W2160027999 @default.
• W2020709481 cites W2166046235 @default.
• W2020709481 cites W2416148102 @default.
• W2020709481 cites W2980580784 @default.
• W2020709481 cites W35202944 @default.
• W2020709481 doi "https://doi.org/10.1016/j.bbmt.2010.02.018" @default.
• W2020709481 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3625653" @default.
• W2020709481 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/20188202" @default.
• W2020709481 hasPublicationYear "2010" @default.
• W2020709481 type Work @default.
• W2020709481 sameAs 2020709481 @default.
• W2020709481 citedByCount "73" @default.
• W2020709481 countsByYear W20207094812012 @default.
• W2020709481 countsByYear W20207094812013 @default.
• W2020709481 countsByYear W20207094812014 @default.
• W2020709481 countsByYear W20207094812015 @default.
• W2020709481 countsByYear W20207094812016 @default.
• W2020709481 countsByYear W20207094812017 @default.
• W2020709481 countsByYear W20207094812018 @default.
• W2020709481 countsByYear W20207094812019 @default.
• W2020709481 countsByYear W20207094812020 @default.
• W2020709481 countsByYear W20207094812021 @default.
• W2020709481 countsByYear W20207094812022 @default.
• W2020709481 countsByYear W20207094812023 @default.
• W2020709481 crossrefType "journal-article" @default.
• W2020709481 hasAuthorship W2020709481A5013466160 @default.
• W2020709481 hasAuthorship W2020709481A5018522179 @default.
• W2020709481 hasAuthorship W2020709481A5018922885 @default.
• W2020709481 hasAuthorship W2020709481A5022333191 @default.
• W2020709481 hasAuthorship W2020709481A5027756167 @default.
• W2020709481 hasAuthorship W2020709481A5029909593 @default.
• W2020709481 hasAuthorship W2020709481A5033550793 @default.
• W2020709481 hasAuthorship W2020709481A5034651124 @default.
• W2020709481 hasAuthorship W2020709481A5037247107 @default.
• W2020709481 hasAuthorship W2020709481A5038246773 @default.
• W2020709481 hasAuthorship W2020709481A5043054254 @default.
• W2020709481 hasAuthorship W2020709481A5061865992 @default.
• W2020709481 hasAuthorship W2020709481A5071675435 @default.
• W2020709481 hasAuthorship W2020709481A5077339824 @default.
• W2020709481 hasAuthorship W2020709481A5081957836 @default.
• W2020709481 hasAuthorship W2020709481A5083678047 @default.
• W2020709481 hasAuthorship W2020709481A5090348866 @default.
• W2020709481 hasAuthorship W2020709481A5091207091 @default.
• W2020709481 hasBestOaLocation W20207094811 @default.
• W2020709481 hasConcept C126322002 @default.
• W2020709481 hasConcept C147483822 @default.
• W2020709481 hasConcept C1491633281 @default.
• W2020709481 hasConcept C154317977 @default.
• W2020709481 hasConcept C188280979 @default.
• W2020709481 hasConcept C202751555 @default.

• next